CoChat

A Brief History of the Development of Diabetes Medications

Open access
White, John R. · 2014 · Diabetes Spectrum
Cited by 177

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

In Brief This article provides an overview of the development of insulins, oral agents, and noninsulin injectable agents used in the management of hyperglycemia in patients with diabetes. It also briefly reviews the pharmacological impact and salient side effects of these medications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diaspect.27.2.82

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Sanders, 2002, From Thebes to Toronto and the 21st century: an incredible journey, Diabetes Spectrum, 15, 56, 10.2337/diaspect.15.1.56 · doi:10.2337/diaspect.15.1.56
  2. Galloway, 1988, Diabetes Mellitus
  3. Daneman, 1981, Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome), Diabetes Care, 4, 360, 10.2337/diacare.4.3.360 · DOI · Paper page
  4. White, 2008, Overview of the medications used to treat type 2 diabetes, 5
  5. Frank, 1926, Über synthetische dargestellte Korper mit Insulinartiger Wirkung auf den normallen und diabetisched Organismus, Klin Wchnschr, 5, 2011, 10.1007/BF01736560 · DOI
  6. Alberti, 1997, International Textbook of Diabetes Mellitus
  7. Levine, 1984, Sulfonylureas: background and development of the field, Diabetes Care, 7, 3
  8. Quianzon, 2012, History of current non-insulin medications for diabetes mellitus, J Community Hosp Intern Med Perspect., 10.3402/jchimp.v2i3.19081 · DOI
  9. Kendall, 2006, Thiazolidinediones: the case for early use, Diabetes Care, 29, 154, 10.2337/diacare.29.01.06.dc05-0711 · DOI · Paper page
  10. Aroda, 2011, The safety and tolerability of GLP-1 receptor agonist in the treatment of type 2 diabetes: a review, Diabetes Metab Res Rev, 27, 528, 10.1002/dmrr.1202 · DOI · Paper page
  11. Neumiller, 2009, Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonist and DPP-4 inhibitors, J Am Pharm Assoc, 49, S14
  12. White, 2010, Apple trees to sodium glucose co-transporter inhibitors: a review of SGLT-2 inhibition, Clinical Diabetes, 28, 5, 10.2337/diaclin.28.1.5 · DOI
  13. Monami, 2013, Efficacy and safety of sodium glucose cotransport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials, Diabetes Obes Metab.
  14. Goodkin, 1975, Mortality factors in diabetes: a 20 year mortality study [Abstract], J Occup Med, 17, 716

Cited by

See all 177

Metadata

Authors
White, J. R.
Venue
Diabetes Spectrum
Published
2014-05-01
Volume
27
Issue
2
Pages
82-86
ISSN
  • 1040-9165 (ISSN-L)
  • 1944-7353
OpenAlex
W2041652400
Cited by
177
References
4
FWCI
3.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.